Role of surface chemistry in modulating drug release kinetics in titania nanotubes
暂无分享,去创建一个
Aninda J. Bhattacharyya | Soumit S Mandal | A. J. Bhattacharyya | D. Jose | Deena Jose | Soumit S. Mandal | Deena Jose
[1] S. Das,et al. Effects of surface acidity and pore size of mesoporous alumina on degree of loading and controlled release of ibuprofen , 2009 .
[2] B D Boyan,et al. Role of material surfaces in regulating bone and cartilage cell response. , 1996, Biomaterials.
[3] N. Peppas,et al. Present and future applications of biomaterials in controlled drug delivery systems. , 1981, Biomaterials.
[4] Victor S-Y Lin,et al. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. , 2007, Journal of the American Chemical Society.
[5] M. Vallet‐Regí,et al. Mesoporous MCM-41 as Drug Host System , 2003 .
[6] Yufang Zhu,et al. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. , 2005, Angewandte Chemie.
[7] A. J. Bhattacharyya,et al. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[8] Alastair J. Florence,et al. Refinement of Ibuprofen at 100K by Single-Crystal Pulsed Neutron Diffraction , 1997 .
[9] M. Vallet‐Regí,et al. Anti-Osteoporotic Drug Release from Ordered Mesoporous Bioceramics: Experiments and Modeling , 2011, AAPS PharmSciTech.
[10] M. Vallet‐Regí,et al. Advanced Drug Delivery Vectors with Tailored Surface Properties Made of Mesoporous Binary Oxides Submicronic Spheres , 2010 .
[11] M. Vallet‐Regí,et al. Influence of pore size of MCM-41 matrices on drug delivery rate , 2004 .
[12] Tejal A Desai,et al. Titania nanotubes: a novel platform for drug-eluting coatings for medical implants? , 2007, Small.
[13] Tejal A Desai,et al. Influence of engineered titania nanotubular surfaces on bone cells. , 2007, Biomaterials.
[14] M. Vallet‐Regí,et al. A New Property of MCM-41: Drug Delivery System , 2001 .
[15] J. Giraldo,et al. Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models. , 2002, Pharmacology & therapeutics.
[16] William I. F. David,et al. Structure solution of Ibuprofen from powder diffraction data by the application of a genetic algorithm combined with prior conformational analysis , 1998 .
[17] V. Khutoryanskiy,et al. Chitosan-based mucoadhesive tablets for oral delivery of ibuprofen. , 2012, International journal of pharmaceutics.
[18] A. Weidenkaff,et al. Mesoporous structure and phase transition of nanocrystalline TiO2 , 2002 .
[19] María Vallet-Regí,et al. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern , 2006 .
[20] S. Das,et al. High Lithium Storage in Mixed Crystallographic Phase Nanotubes of Titania and Carbon-Titania , 2009 .
[21] María Vallet-Regí,et al. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. , 2006, Chemistry.
[22] M. Hartmann. Ordered Mesoporous Materials for Bioadsorption and Biocatalysis , 2005 .
[23] R. Cloots,et al. Ag- and SiO2-doped porous TiO2 with enhanced thermal stability , 2009 .
[24] Aninda J. Bhattacharyya,et al. Ultrasound-Triggered Controlled Drug Delivery and Biosensing Using Silica Nanotubes , 2009 .
[25] M. Coppens,et al. Synthesis and structure of silicalite-1/SBA-15 composites prepared by carbon templating and crystallization , 2007 .
[26] C. C. Landry,et al. Diffusion-based deprotection in mesoporous materials: a strategy for differential functionalization of porous silica particles. , 2007, Journal of the American Chemical Society.